Spinal Muscular Atrophy Movement Defects Cause Possibly Found Discovery Of Possible In cause of movement defects in spinal muscular atrophy identified Scientists find possible

Spinal Muscular Atrophy: Avery's Bucket List Blog Raises Awareness Of The Disease, But What Is It? A newborn baby's battle with spinal muscular atrophy inspired her parents to start a bucket list blog. HULIQ reports on Avery's Bucket List blog, a site that aims to spread awareness of Avery's illness, which progressively weakens muscle function. Repligen Reports Positive Results From Phase 1 Clinical Trial for Spinal Muscular Atrophy (SMA) ELK GROVE VILLAGE, Ill. -- Repligen Corporation today announced positive results from a Phase 1 study to evaluate the pharmacokinetic (PK) and safety profile of RG3039, a novel small molecule drug candidate ... Avery Canahuati's Bucket List Goes Viral After Laura and Mike Canahuati of Houston, T.X. received the call from their neurologist which confirmed their worst fear: their little girl had been diagnosed with spinal muscular atrophy and had a mere 18 months to live. This is when the Canahuatis created "Avery's Bucket List," a blog composed of their daughter's adventures, written from [...] Avery Canahuati's Bucket List Goes Viral is a ... Repligen Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy Repligen Corporation today announced positive results from a Phase 1 study to evaluate the pharmacokinetic and safety profile of RG3039, a novel small molecule drug candidate for the potential treatment of spinal muscular atrophy . Spinal Muscular Atrophy - Movement Defects Cause Possibly Found According to a study published in the April 11 issue of The Journal of Neuroscience, researchers have found that an abnormally low level of survival motor neuron protein (SMN), in certain nerve cells, is associated with mobility problems that characterize spinal muscular atrophy (SMA) - a deadly childhood disorder. SMA is a genetic disorder in which motor neurons do not produce enough SMN. Motor ... The Spinal Muscular Atrophy Foundation Announces a Biomarker Panel to Guide SMA Therapeutic Development NEW YORK, April 3, 2012 /PRNewswire/ -- The Spinal Muscular Atrophy (SMA) Foundation announced today the launch of a biomarker assay panel for SMA using Myriad RBM's Multi-Analyte Profiling (MAP) technology ... Possible cause of movement defects in spinal muscular atrophy identified An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests. Scientists find possible cause of movement defects in spinal muscular atrophy ( Ohio State University ) An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests. Repligen Announces Favorable Results from Phase 1 Clinical Trial of Experimental Treatment for Spinal Muscular Atrophy TUCSON, Ariz., April 25, 2012 /PRNewswire-USNewswire/ -- Repligen Corp., in Waltham, Mass., announced today that its experimental drug RG3039, designed to treat spinal muscular atrophy (SMA), was safe and well-tolerated in a phase 1 clinical trial. In addition, data suggested that the drug reached and acted on its biological target, an enzyme called DcpS. Positive results from Repligen's RG3039 Phase 1 study for spinal muscular atrophy Repligen Corporation today announced positive results from a Phase 1 study to evaluate the pharmacokinetic (PK) and safety profile of RG3039, a novel small molecule drug candidate for the potential treatment of spinal muscular atrophy (SMA).
Key Words: spinal muscular atrophy

References:
http://feedproxy.google.com/~r/mnt/healthnews/~3/dYXKxXDeM-E/244147.php
http://feedproxy.google.com/~r/mnt/healthnews/~3/xz46IzhmAd4/244036.php
http://feeds.sciencedaily.com/~r/sciencedaily/~3/RHeUNdenpZ4/120411102723.htm
http://pixelhat.net/